메뉴 건너뛰기




Volumn 14, Issue 2, 2012, Pages 101-111

Psychopharmacological treatments in HIV patients under antiretroviral therapy

Author keywords

Antiretroviral therapy; HIV; Psychopharmacological treatments; Psychotropic medication

Indexed keywords

AGOMELATINE; ALPRAZOLAM; AMFEBUTAMONE; BENZODIAZEPINE; BUPRENORPHINE; CLONAZEPAM; EFAVIRENZ; ENFUVIRTIDE; ETRAVIRINE; FLUOXETINE; HALOPERIDOL; LITHIUM; MARAVIROC; METHADONE; METHYLPHENIDATE; NALTREXONE; NEFAZODONE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; OLANZAPINE; PREGABALIN; PROTEINASE INHIBITOR; RALTEGRAVIR; REBOXETINE; RITONAVIR; SERTRALINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIDOVUDINE;

EID: 84862550149     PISSN: 11396121     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (16)

References (90)
  • 2
    • 42449085034 scopus 로고    scopus 로고
    • Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients
    • Horberg M, Silverberg M, Hurley L, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. J Acquir Immune Defic Syndr. 2008;47:384-90.
    • (2008) J Acquir Immune Defic Syndr , vol.47 , pp. 384-390
    • Horberg, M.1    Silverberg, M.2    Hurley, L.3
  • 3
    • 15044359069 scopus 로고    scopus 로고
    • Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients
    • Yun L, Maravi M, Kobayashi J, Barton P, Davidson A. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:432-8.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 432-438
    • Yun, L.1    Maravi, M.2    Kobayashi, J.3    Barton, P.4    Davidson, A.5
  • 4
    • 33846027983 scopus 로고    scopus 로고
    • Practice Guidelines for the Treatment of Psychiatric Disorders
    • American Psychiatric Association. American Psychiatric Association
    • American Psychiatric Association. Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2006. American Psychiatric Association 2006.
    • (2006) Compendium 2006
  • 5
    • 0037362750 scopus 로고    scopus 로고
    • Use of Psychotropic Medications among HIV-Infected Patients in the United States
    • Vitiello B, Burnam M, Bing E, Beckman R, Shapiro M. Use of Psychotropic Medications Among HIV-Infected Patients in the United States. Am J Psychiatry. 2003;160:547-54.
    • (2003) Am J Psychiatry , vol.160 , pp. 547-554
    • Vitiello, B.1    Burnam, M.2    Bing, E.3    Beckman, R.4    Shapiro, M.5
  • 7
    • 0032940948 scopus 로고    scopus 로고
    • Significant interactions with new antiretrovirals and psychotropic drugs
    • Tseng A, Foisy M. Significant interactions with new antiretrovirals and psychotropic drugs. Ann Pharmacother. 1999;33:461-73.
    • (1999) Ann Pharmacother , vol.33 , pp. 461-473
    • Tseng, A.1    Foisy, M.2
  • 8
    • 0037049347 scopus 로고    scopus 로고
    • Incidence of adipose tissue alterations in first-line antiretroviral therapy: The LipoICoNa Study
    • Galli M, Cozzi-Lepri A, Ridolfo A, et al. Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study. Arch Intern Med. 2002;162:2621-8.
    • (2002) Arch Intern Med , vol.162 , pp. 2621-2628
    • Galli, M.1    Cozzi-Lepri, A.2    Ridolfo, A.3
  • 9
    • 0034631873 scopus 로고    scopus 로고
    • Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study
    • Tsiodras S, Mantzoros C, Hammer S, et al. Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study. Arch Intern Med. 2000;160:2050-6.
    • (2000) Arch Intern Med , vol.160 , pp. 2050-2056
    • Tsiodras, S.1    Mantzoros, C.2    Hammer, S.3
  • 10
    • 0012570692 scopus 로고    scopus 로고
    • Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: Preliminary results of the LIPOCO study
    • Saint-Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS. 2000;14:37-49.
    • (2000) AIDS , vol.14 , pp. 37-49
    • Saint-Marc, T.1    Partisani, M.2    Poizot-Martin, I.3
  • 12
    • 0033730425 scopus 로고    scopus 로고
    • Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
    • Maggi P, Serio G, Epifani G, et al. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors. AIDS. 2000;14:F123-8.
    • (2000) AIDS , vol.14
    • Maggi, P.1    Serio, G.2    Epifani, G.3
  • 13
    • 17144463863 scopus 로고    scopus 로고
    • Severe premature coronary artery disease with protease inhibitors
    • Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328.
    • (1998) Lancet , vol.351 , pp. 1328
    • Henry, K.1    Melroe, H.2    Huebsch, J.3
  • 14
    • 0033527333 scopus 로고    scopus 로고
    • Myocardial infarction in HIV-infected men receiving protease inhibitors
    • Flynn T, Bricker L. Myocardial infarction in HIV-infected men receiving protease inhibitors. Ann Intern Med. 1999;131:548.
    • (1999) Ann Intern Med , vol.131 , pp. 548
    • Flynn, T.1    Bricker, L.2
  • 15
    • 17444405568 scopus 로고    scopus 로고
    • Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: A cross-sectional study
    • Mackin P, Watkinson H, Young A. Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia. 2005;48:215-21.
    • (2005) Diabetologia , vol.48 , pp. 215-221
    • Mackin, P.1    Watkinson, H.2    Young, A.3
  • 16
    • 13244294222 scopus 로고    scopus 로고
    • A review of metabolic issues in atypical antipsychotic treatment
    • Newcomer J, Nasrallah H. A review of metabolic issues in atypical antipsychotic treatment. Adv Studies Med. 2004;4:S1045-58.
    • (2004) Adv Studies Med , vol.4
    • Newcomer, J.1    Nasrallah, H.2
  • 17
    • 27744581955 scopus 로고    scopus 로고
    • A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
    • Goff D, Sullivan L, McEvoy J, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80:45-53.
    • (2005) Schizophr Res , vol.80 , pp. 45-53
    • Goff, D.1    Sullivan, L.2    McEvoy, J.3
  • 18
    • 0028268944 scopus 로고
    • Use of psychotropic drugs in patients with HIV infection
    • Ayuso J. Use of psychotropic drugs in patients with HIV infection. Drugs. 1994;47:599-610.
    • (1994) Drugs , vol.47 , pp. 599-610
    • Ayuso, J.1
  • 19
    • 0033746611 scopus 로고    scopus 로고
    • Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia
    • Nath A, Anderson C, Jones M, et al. Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol. 2000;14:222-7.
    • (2000) J Psychopharmacol , vol.14 , pp. 222-227
    • Nath, A.1    Anderson, C.2    Jones, M.3
  • 20
    • 14544267602 scopus 로고    scopus 로고
    • Drug interactions in the management of HIV infection
    • Robertson S, Penzak S, Pau A. Drug interactions in the management of HIV infection. Expert Opin Pharmacother. 2005;6:233-53.
    • (2005) Expert Opin Pharmacother , vol.6 , pp. 233-253
    • Robertson, S.1    Penzak, S.2    Pau, A.3
  • 21
    • 0034455640 scopus 로고    scopus 로고
    • Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection
    • Gerber J. Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection. Clin Infect Dis. 2000;30:S123-9.
    • (2000) Clin Infect Dis , vol.30
    • Gerber, J.1
  • 22
    • 0030756282 scopus 로고    scopus 로고
    • Drug interaction potential with inhibitors of HIV protease
    • Van Cleef G, Fisher E, Polk R. Drug interaction potential with inhibitors of HIV protease. Pharmacotherapy. 1997;17:774-8.
    • (1997) Pharmacotherapy , vol.17 , pp. 774-778
    • Van Cleef, G.1    Fisher, E.2    Polk, R.3
  • 23
    • 0032556976 scopus 로고    scopus 로고
    • Drug interactions in HIV-positive patients initiated on protease inhibitor therapy
    • Preston S, Postelnick M, Purdy B, et al. Drug interactions in HIV-positive patients initiated on protease inhibitor therapy. AIDS. 1998;12:228-30.
    • (1998) AIDS , vol.12 , pp. 228-230
    • Preston, S.1    Postelnick, M.2    Purdy, B.3
  • 25
    • 50949103536 scopus 로고    scopus 로고
    • Psychopharmacology in HIV-infected patients
    • Repetto M, Petitto J. Psychopharmacology in HIV-infected patients. Psychosom Med. 2008;70:585-92.
    • (2008) Psychosom Med , vol.70 , pp. 585-592
    • Repetto, M.1    Petitto, J.2
  • 26
    • 0024440344 scopus 로고
    • Anxiety and neuropsychiatry of AIDS
    • Fernandez F. Anxiety and neuropsychiatry of AIDS. J Clin Psychiatry. 1989;50:9-14.
    • (1989) J Clin Psychiatry , vol.50 , pp. 9-14
    • Fernandez, F.1
  • 28
    • 0034056369 scopus 로고    scopus 로고
    • Alprazolam-ritonavir interactions: Implications for product labelling
    • Greenblatt D, von Moltke L, Harmatz J, et al. Alprazolam-ritonavir interactions: implications for product labelling. Clin Pharmacol Ther. 2000;67:335-47.
    • (2000) Clin Pharmacol Ther , vol.67 , pp. 335-347
    • Greenblatt, D.1    Von Moltke, L.2    Harmatz, J.3
  • 29
    • 0034209862 scopus 로고    scopus 로고
    • Differential impairment of triazolam and zolpidem clearance by ritonavir
    • Greenblatt D, von Moltke L, Harmatz J, et al. Differential impairment of triazolam and zolpidem clearance by ritonavir. J Acquir Immune Defic Syndr. 2000;24:129-36.
    • (2000) J Acquir Immune Defic Syndr , vol.24 , pp. 129-136
    • Greenblatt, D.1    Von Moltke, L.2    Harmatz, J.3
  • 32
    • 78649655790 scopus 로고    scopus 로고
    • Psychiatric treatment of persons with HIV/AIDS: An HIV-psychiatry consensus survey of current practices
    • Freudenreich O, Goforth H, Cozza K, et al. Psychiatric treatment of persons with HIV/AIDS: an HIV-psychiatry consensus survey of current practices. Psychosomatics. 2010;51:480-8
    • (2010) Psychosomatics , vol.51 , pp. 480-488
    • Freudenreich, O.1    Goforth, H.2    Cozza, K.3
  • 33
    • 67650472819 scopus 로고    scopus 로고
    • The pharmacologic management of insomnia in patients with HIV
    • Omonuwa T, Goforth H, Preud'homme X, et al. The pharmacologic management of insomnia in patients with HIV. J Clin Sleep Med. 2009;5:251-62.
    • (2009) J Clin Sleep Med , vol.5 , pp. 251-262
    • Omonuwa, T.1    Goforth, H.2    Preud'homme, X.3
  • 34
    • 0025293443 scopus 로고
    • Buspirone in drug users with AIDS or AIDS-related complex
    • Batki S. Buspirone in drug users with AIDS or AIDS-related complex. J Clin Psychopharmacol. 1990;10:111-15S.
    • (1990) J Clin Psychopharmacol , vol.10
    • Batki, S.1
  • 35
    • 32944482387 scopus 로고    scopus 로고
    • An overview of psychotropic drugdrug interactions
    • Sandson N, Armstrong S, Cozza K. An overview of psychotropic drugdrug interactions. Psychosomatics. 2005;46:464-94.
    • (2005) Psychosomatics , vol.46 , pp. 464-494
    • Sandson, N.1    Armstrong, S.2    Cozza, K.3
  • 36
    • 77955714260 scopus 로고    scopus 로고
    • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
    • Altice F, Kamarulzaman A, Soriano V, Schechter M, Friedland G. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376:367-87.
    • (2010) Lancet , vol.376 , pp. 367-387
    • Altice, F.1    Kamarulzaman, A.2    Soriano, V.3    Schechter, M.4    Friedland, G.5
  • 37
    • 0035885023 scopus 로고    scopus 로고
    • Management of psychiatric disorders in patients infected with human immunodeficiency virus
    • Angelino A, Treisman G. Management of psychiatric disorders in patients infected with human immunodeficiency virus. Clin Infect Dis. 2001;33:847-56.
    • (2001) Clin Infect Dis , vol.33 , pp. 847-856
    • Angelino, A.1    Treisman, G.2
  • 38
    • 0036511084 scopus 로고    scopus 로고
    • Psychopharmacological treatment of patients with HIV and AIDS
    • Ferrando S, Wapanyi K. Psychopharmacological treatment of patients with HIV and AIDS. Psychiatr Q. 2002;73:33-49.
    • (2002) Psychiatr Q , vol.73 , pp. 33-49
    • Ferrando, S.1    Wapanyi, K.2
  • 39
    • 0028354623 scopus 로고
    • Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness
    • Rabkin J, Rabkin R, Harrison W, Wagner G. Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness. Am J Psychiatry. 1994;151:516-23.
    • (1994) Am J Psychiatry , vol.151 , pp. 516-523
    • Rabkin, J.1    Rabkin, R.2    Harrison, W.3    Wagner, G.4
  • 40
    • 0034177434 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability
    • Anderson I. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord. 2000;58:19-36.
    • (2000) J Affect Disord , vol.58 , pp. 19-36
    • Anderson, I.1
  • 41
    • 0032734478 scopus 로고    scopus 로고
    • Antidepressant treatment of depression in HIV-seropositive women
    • Ferrando S, Rabkin J, de Moore G, Rabkin R. Antidepressant treatment of depression in HIV-seropositive women. J Clin Psychiatry. 1999;60:741-6.
    • (1999) J Clin Psychiatry , vol.60 , pp. 741-746
    • Ferrando, S.1    Rabkin, J.2    De Moore, G.3    Rabkin, R.4
  • 42
    • 0030889634 scopus 로고    scopus 로고
    • Efficacy of paroxetine for treatment of depression in the context of HIV infection
    • Grassi B, Gambini O, Graghentini A, et al. Efficacy of paroxetine for treatment of depression in the context of HIV infection. Pharmacotherapy. 1997;30:70-1.
    • (1997) Pharmacotherapy , vol.30 , pp. 70-71
    • Grassi, B.1    Gambini, O.2    Graghentini, A.3
  • 43
    • 0031924994 scopus 로고    scopus 로고
    • Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants
    • Baker G, Fang J, Sinha S, Coutts R. Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) antidepressants. Neurosci Biobehav Rev. 1998;22:325-33.
    • (1998) Neurosci Biobehav Rev , vol.22 , pp. 325-333
    • Baker, G.1    Fang, J.2    Sinha, S.3    Coutts, R.4
  • 44
    • 0036219021 scopus 로고    scopus 로고
    • Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: An update
    • Hemeryck A, Belpaire F. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab. 2002;3:13-37.
    • (2002) Curr Drug Metab , vol.3 , pp. 13-37
    • Hemeryck, A.1    Belpaire, F.2
  • 45
    • 11144238371 scopus 로고    scopus 로고
    • Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV
    • Caballero J, Nahata M. Use of selective serotonin-reuptake inhibitors in the treatment of depression in adults with HIV. Ann Pharmacother. 2005;39:141-5.
    • (2005) Ann Pharmacother , vol.39 , pp. 141-145
    • Caballero, J.1    Nahata, M.2
  • 46
    • 2442529601 scopus 로고    scopus 로고
    • Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: A prospective study
    • Currier M, Molina G, Kato M. Citalopram treatment of major depressive disorder in Hispanic HIV and AIDS patients: a prospective study. Psychosomatics. 2004;45:210-16.
    • (2004) Psychosomatics , vol.45 , pp. 210-216
    • Currier, M.1    Molina, G.2    Kato, M.3
  • 47
    • 28344442596 scopus 로고    scopus 로고
    • Duloxetine: A balanced and selective norepinephrine and serotonin-reuptake inhibitor
    • Westanmo A, Gayken J, Haight R. Duloxetine: a balanced and selective norepinephrine and serotonin-reuptake inhibitor. Am J Health Syst Pharm. 2005;62:2481-90.
    • (2005) Am J Health Syst Pharm , vol.62 , pp. 2481-2490
    • Westanmo, A.1    Gayken, J.2    Haight, R.3
  • 48
    • 79951996267 scopus 로고    scopus 로고
    • Desvenlafaxine in major depressive disorder: An evidence-based review of its place in therapy
    • Lieberman D, Massey S. Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Core Evid. 2009;4:67-82.
    • (2009) Core Evid , vol.4 , pp. 67-82
    • Lieberman, D.1    Massey, S.2
  • 49
    • 0038710739 scopus 로고    scopus 로고
    • An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder
    • Carvalhal A, de Abreu P, Spode A, Correa J, Kapczinski F. An open trial of reboxetine in HIV-seropositive outpatients with major depressive disorder. J Clin Psychiatry. 2003;64:421-4.
    • (2003) J Clin Psychiatry , vol.64 , pp. 421-424
    • Carvalhal, A.1    De Abreu, P.2    Spode, A.3    Correa, J.4    Kapczinski, F.5
  • 50
    • 0037369155 scopus 로고    scopus 로고
    • A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients
    • Currier M, Molina G, Kato M. A prospective trial of sustained-release bupropion for depression in HIV-seropositive and AIDS patients. Psychosomatics. 2003;44:120-5.
    • (2003) Psychosomatics , vol.44 , pp. 120-125
    • Currier, M.1    Molina, G.2    Kato, M.3
  • 51
    • 0035150854 scopus 로고    scopus 로고
    • Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: Potential drug interactions with bupropion
    • Hesse L, von Moltke L, Shader R, Greenblatt D. Ritonavir, efavirenz, and nelfinavir inhibit CYP2B6 activity in vitro: potential drug interactions with bupropion. Drug Metab Dispos. 2001;29:100-2.
    • (2001) Drug Metab Dispos , vol.29 , pp. 100-102
    • Hesse, L.1    Von Moltke, L.2    Shader, R.3    Greenblatt, D.4
  • 52
    • 0032908843 scopus 로고    scopus 로고
    • Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: An open trial of nefazodone
    • Elliott A, Russo J, Bergam K, Claypoole K, Uldall K, Roy-Byrne P. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone. J Clin Psychiatry. 1999;60:226-31.
    • (1999) J Clin Psychiatry , vol.60 , pp. 226-231
    • Elliott, A.1    Russo, J.2    Bergam, K.3    Claypoole, K.4    Uldall, K.5    Roy-Byrne, P.6
  • 53
    • 0037382219 scopus 로고    scopus 로고
    • Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone
    • Greenblatt D, von Moltke L, Harmatz J, et al. Short-term exposure to low-dose ritonavir impairs clearance and enhances adverse effects of trazodone. J Clin Pharmacol. 2003;43:414-22.
    • (2003) J Clin Pharmacol , vol.43 , pp. 414-422
    • Greenblatt, D.1    Von Moltke, L.2    Harmatz, J.3
  • 54
    • 0034128559 scopus 로고    scopus 로고
    • Mirtazapine for depression in patients with human immunodeficiency virus
    • Elliott A, Roy-Byrne P. Mirtazapine for depression in patients with human immunodeficiency virus. J Clin Psychopharmacol. 2000;20:265-7.
    • (2000) J Clin Psychopharmacol , vol.20 , pp. 265-267
    • Elliott, A.1    Roy-Byrne, P.2
  • 55
    • 80051796810 scopus 로고    scopus 로고
    • Novel melatonin-based therapies: Potential advances in the treatment of major depression
    • Hickie I, Rogers N. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet. 2011;378:621-31.
    • (2011) Lancet , vol.378 , pp. 621-631
    • Hickie, I.1    Rogers, N.2
  • 56
    • 76149131974 scopus 로고    scopus 로고
    • Agomelatine: A novel pharmacological approach to treating depression
    • Barc
    • Owen R. Agomelatine: a novel pharmacological approach to treating depression. Drugs Today (Barc). 2009;45:599-608.
    • (2009) Drugs Today , vol.45 , pp. 599-608
    • Owen, R.1
  • 57
    • 0029047853 scopus 로고
    • Effects of methylphenidate in HIV-related depression: A comparative trial with deispramine
    • Fernandez F, Levy J, Samley H, et al. Effects of methylphenidate in HIV-related depression: a comparative trial with deispramine. Int J Psychiatry Med. 1995;25:53-67.
    • (1995) Int J Psychiatry Med , vol.25 , pp. 53-67
    • Fernandez, F.1    Levy, J.2    Samley, H.3
  • 58
    • 0033947427 scopus 로고    scopus 로고
    • Effects of dextroamphetamine on depression and fatigue in men with HIV: A double-blind placebo controlled trial
    • Wagner G, Rabkin R. Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind placebo controlled trial. J Clin Psychiatry. 2000;61:436-40.
    • (2000) J Clin Psychiatry , vol.61 , pp. 436-440
    • Wagner, G.1    Rabkin, R.2
  • 59
    • 0035847581 scopus 로고    scopus 로고
    • A randomized, double- Blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus
    • Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J. A randomized, double- blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus. Arch Intern Med. 2001;161:411-20.
    • (2001) Arch Intern Med , vol.161 , pp. 411-420
    • Breitbart, W.1    Rosenfeld, B.2    Kaim, M.3    Funesti-Esch, J.4
  • 60
    • 0024237865 scopus 로고
    • Effect of lithium carbonate in HIV-infected patients with immune dysfunction
    • Parenti D, Simon G, Scheib R, et al. Effect of lithium carbonate in HIV-infected patients with immune dysfunction. J Acquir Immune Defic Syndr. 1988;1:119-24.
    • (1988) J Acquir Immune Defic Syndr , vol.1 , pp. 119-124
    • Parenti, D.1    Simon, G.2    Scheib, R.3
  • 61
    • 33748488655 scopus 로고    scopus 로고
    • Lithium improves HIV-associated neurocognitive impairment
    • HNRC Group
    • Letendre S, Woods S, Ellis R, et al. HNRC Group. Lithium improves HIV-associated neurocognitive impairment. AIDS. 2006;20:1885-8.
    • (2006) AIDS , vol.20 , pp. 1885-1888
    • Letendre, S.1    Woods, S.2    Ellis, R.3
  • 62
    • 0029791026 scopus 로고    scopus 로고
    • Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels
    • Moog C, Kuntz-Simon G, Caussin-Schwemling C, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels. J Gen Virol. 1996;77:1993-9.
    • (1996) J Gen Virol , vol.77 , pp. 1993-1999
    • Moog, C.1    Kuntz-Simon, G.2    Caussin-Schwemling, C.3    Obert, G.4
  • 63
    • 33750485028 scopus 로고    scopus 로고
    • Valproic acid does not affect markers of human immunodeficiency virus disease progression
    • Ances B, Letendre S, Buzzell M, et al. Valproic acid does not affect markers of human immunodeficiency virus disease progression. J Neurovirol. 2006;12:403-6.
    • (2006) J Neurovirol , vol.12 , pp. 403-406
    • Ances, B.1    Letendre, S.2    Buzzell, M.3
  • 64
    • 0038037673 scopus 로고    scopus 로고
    • Concurrent use of antiretrovirals and anticonvulsants in human immunodeficiency virus (HIV) seropositive patients
    • Romanelli F, Pomeroy C. Concurrent use of antiretrovirals and anticonvulsants in human immunodeficiency virus (HIV) seropositive patients. Curr Pharm Des. 2003;9:1433-9.
    • (2003) Curr Pharm des , vol.9 , pp. 1433-1439
    • Romanelli, F.1    Pomeroy, C.2
  • 65
    • 57649134379 scopus 로고    scopus 로고
    • Antiepileptic drug interactions
    • Díaz R, Sancho J, Serratosa J. Antiepileptic drug interactions. Neurologist. 2008;14(Suppl 1):S55-65.
    • (2008) Neurologist , vol.14 , Issue.SUPPL. 1
    • Díaz, R.1    Sancho, J.2    Serratosa, J.3
  • 67
    • 0034127381 scopus 로고    scopus 로고
    • Carbamazepine-indinavir interaction causes antiretroviral therapy failure
    • Hugen P, Burger D, Brinkman K, et al. Carbamazepine-indinavir interaction causes antiretroviral therapy failure. Ann Pharmacother. 2000;34:465-70.
    • (2000) Ann Pharmacother , vol.34 , pp. 465-470
    • Hugen, P.1    Burger, D.2    Brinkman, K.3
  • 68
    • 0037545484 scopus 로고    scopus 로고
    • Lamotrigine for HIV-associated painful sensory neuropathies: A placebo controlled trial
    • Simpson D, McArthur J, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo controlled trial. Neurology. 2003;60:1508-14.
    • (2003) Neurology , vol.60 , pp. 1508-1514
    • Simpson, D.1    McArthur, J.2    Olney, R.3
  • 69
    • 33746752084 scopus 로고    scopus 로고
    • Lopinavir/ritonavir reduces lamotrigine plasma concentrations in health subjects
    • van der Lee M, Dawood L, ter Hofstede HJ, et al. Lopinavir/ritonavir reduces lamotrigine plasma concentrations in health subjects. Clin Pharmacol Ther. 2006;80:159-68.
    • (2006) Clin Pharmacol Ther , vol.80 , pp. 159-168
    • Van Der Lee, M.1    Dawood, L.2    Ter Hofstede, H.J.3
  • 70
    • 8744261620 scopus 로고    scopus 로고
    • German Neuro-AIDS Working Group. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies
    • Hahn K, Arendt G, Braun J, et al. German Neuro-AIDS Working Group. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004;251:1260-6.
    • (2004) J Neurol , vol.251 , pp. 1260-1266
    • Hahn, K.1    Arendt, G.2    Braun, J.3
  • 71
    • 36949037520 scopus 로고    scopus 로고
    • Antiepileptic drugs in non-epilepsy disorders: Relations between mechanisms of action and clinical efficacy
    • Landmark C. Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22:27-47.
    • (2008) CNS Drugs , vol.22 , pp. 27-47
    • Landmark, C.1
  • 72
    • 76349097543 scopus 로고    scopus 로고
    • Pregabalin for painful HIV neuropathy: A randomized, double-blind, placebo-controlled trial
    • Simpson D, Schifitto G, Clifford D, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74:413-20.
    • (2010) Neurology , vol.74 , pp. 413-420
    • Simpson, D.1    Schifitto, G.2    Clifford, D.3
  • 73
    • 0028029552 scopus 로고
    • Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: A clinico-pathological case report
    • Factor S, Podskalny G, Barron K. Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case report. J Neurol Sci. 1994;127:114-20.
    • (1994) J Neurol Sci , vol.127 , pp. 114-120
    • Factor, S.1    Podskalny, G.2    Barron, K.3
  • 74
    • 0026093555 scopus 로고
    • Extrapyramidal symptoms due to dopamine blocking agents in patients with AIDS encephalopathy
    • Hriso E, Kuhn T, Masdeu J, Grundham M. Extrapyramidal symptoms due to dopamine blocking agents in patients with AIDS encephalopathy. Am J Psychiatry. 1991;148:1558-61.
    • (1991) Am J Psychiatry , vol.148 , pp. 1558-1561
    • Hriso, E.1    Kuhn, T.2    Masdeu, J.3    Grundham, M.4
  • 75
    • 0032532747 scopus 로고    scopus 로고
    • Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient
    • Meyer J, Marsh J, Simpson G. Differential sensitivities to risperidone and olanzapine in a human immunodeficiency virus patient. Biol Psychiatry. 1998;44:791-4.
    • (1998) Biol Psychiatry , vol.44 , pp. 791-794
    • Meyer, J.1    Marsh, J.2    Simpson, G.3
  • 76
    • 4644354707 scopus 로고    scopus 로고
    • Atypical antipsychotics and metabolic dysregulation: Evaluating the risk/benefit equation and improving the standard of care
    • Nasrallah H, Newcomer J. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol. 2004;24(Suppl 1):S7.
    • (2004) J Clin Psychopharmacol , vol.24 , Issue.SUPPL. 1
    • Nasrallah, H.1    Newcomer, J.2
  • 77
    • 0032945422 scopus 로고    scopus 로고
    • Pilot study with clozapine in patients with HIV associated psychosis and drug-induced Parkinsonism
    • Lera G, Zirulnik J. Pilot study with clozapine in patients with HIV associated psychosis and drug-induced Parkinsonism. Mov Disord. 1999;14:128-31.
    • (1999) Mov Disord , vol.14 , pp. 128-131
    • Lera, G.1    Zirulnik, J.2
  • 78
    • 0036325312 scopus 로고    scopus 로고
    • Influence of ritonavir on olanzapine pharmacokinetics in health volunteers
    • Penzak S, Hon Y, Lawhorn W, et al. Influence of ritonavir on olanzapine pharmacokinetics in health volunteers. J Clin Psychopharmacol. 2002;22:366-70.
    • (2002) J Clin Psychopharmacol , vol.22 , pp. 366-370
    • Penzak, S.1    Hon, Y.2    Lawhorn, W.3
  • 79
    • 0030919357 scopus 로고    scopus 로고
    • Treatment of HIV related psychotic disorders with risperidone: A series of 21 cases
    • Singh A, Golledge H, Catalan J. Treatment of HIV related psychotic disorders with risperidone: a series of 21 cases. J Psychosom Res. 1997;42:489-93.
    • (1997) J Psychosom Res , vol.42 , pp. 489-493
    • Singh, A.1    Golledge, H.2    Catalan, J.3
  • 80
    • 70350516833 scopus 로고    scopus 로고
    • Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients
    • Pollack T, McCoy C, Stead W. Clinically significant adverse events from a drug interaction between quetiapine and atazanavir-ritonavir in two patients. Pharmacotherapy. 2009;29:1386-91.
    • (2009) Pharmacotherapy , vol.29 , pp. 1386-1391
    • Pollack, T.1    McCoy, C.2    Stead, W.3
  • 81
    • 0036785221 scopus 로고    scopus 로고
    • Interactions between recreational drugs and antiretroviral agents
    • Antoniou T, Tseng A. Interactions between recreational drugs and antiretroviral agents. Ann Pharmacother. 2002;36:1598-613.
    • (2002) Ann Pharmacother , vol.36 , pp. 1598-1613
    • Antoniou, T.1    Tseng, A.2
  • 82
    • 33646776797 scopus 로고    scopus 로고
    • Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: Implications and management for clinical practice
    • Bruce R, Altice F, Gourevitch M, Friedland G. Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J Acquir Immune Defic Syndr. 2006;4:563-72.
    • (2006) J Acquir Immune Defic Syndr , vol.4 , pp. 563-572
    • Bruce, R.1    Altice, F.2    Gourevitch, M.3    Friedland, G.4
  • 83
    • 18744399306 scopus 로고    scopus 로고
    • Antiretrovirals. Part III: Antiretrovirals and drugs of abuse
    • Wynn G, Cozza K, Zapor M, et al. Antiretrovirals. Part III: antiretrovirals and drugs of abuse. Psychosomatics. 2005;46:79-87.
    • (2005) Psychosomatics , vol.46 , pp. 79-87
    • Wynn, G.1    Cozza, K.2    Zapor, M.3
  • 84
    • 0038193696 scopus 로고    scopus 로고
    • Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro
    • Wang J, DeVane C. Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro. Drug Metab Dispos. 2003;31:742-7.
    • (2003) Drug Metab Dispos , vol.31 , pp. 742-747
    • Wang, J.1    DeVane, C.2
  • 85
    • 33845388480 scopus 로고    scopus 로고
    • Pharmacokinetic interactions between buprenorphine and antiretroviral medications
    • Bruce R, McCance-Katz E, Karasch E, Moody D, Morse G. Pharmacokinetic interactions between buprenorphine and antiretroviral medications. Clin Infect Dis. 2006;43:S216-23.
    • (2006) Clin Infect Dis , vol.43
    • Bruce, R.1    McCance-Katz, E.2    Karasch, E.3    Moody, D.4    Morse, G.5
  • 86
    • 33845419520 scopus 로고    scopus 로고
    • Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine
    • McCance-Katz E, Moody D, Morse G, et al. Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine. Clin Infect Dis. 2006;43(Suppl 4):S224-34.
    • (2006) Clin Infect Dis , vol.43 , Issue.SUPPL. 4
    • McCance-Katz, E.1    Moody, D.2    Morse, G.3
  • 87
    • 33845416796 scopus 로고    scopus 로고
    • Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ ritonavir, and ritonavir
    • McCance-Katz E, Moody D, Smith P, et al. Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ ritonavir, and ritonavir. Clin Infect Dis. 2006;43(Suppl 4):S235-46.
    • (2006) Clin Infect Dis , vol.43 , Issue.SUPPL. 4
    • McCance-Katz, E.1    Moody, D.2    Smith, P.3
  • 88
    • 0037268147 scopus 로고    scopus 로고
    • Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users
    • Clarke S, Delamere S, McCullough L, et al. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users. HIV Med. 2003;4:33-7.
    • (2003) HIV Med , vol.4 , pp. 33-37
    • Clarke, S.1    Delamere, S.2    McCullough, L.3
  • 89
    • 2342584779 scopus 로고    scopus 로고
    • Drug interactions between opioids and antiretroviral medications: Interaction between methadone, LAAM, and nelfinavir
    • McCance-Katz E, Rainey P, Smith P, et al. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir. Am J Addict. 2004;13:163-80.
    • (2004) Am J Addict , vol.13 , pp. 163-180
    • McCance-Katz, E.1    Rainey, P.2    Smith, P.3
  • 90
    • 7244226310 scopus 로고    scopus 로고
    • Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients
    • Stocker H, Kruse G, Kreckel P, et al. Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2004; 48:4148-53.
    • (2004) Antimicrob Agents Chemother , vol.48 , pp. 4148-4153
    • Stocker, H.1    Kruse, G.2    Kreckel, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.